The Latest Breaking News on Pharma

North American drug developers have signed a deal with a British company to trial the therapeutic benefits of psychedelic medicines in London.

New York (AFP) - US biopharmaceutical firm Amgen said Monday it has reached agreement to acquire Horizon Therapeutics, which specializes in medicine for rare and auto-immune diseases, for $27.8 billion.

Amgen announced a $28.3 billion plan to acquire Horizon Therapeutics on Monday, leading HZNP stock to soar higher.

Six floor office building on New Oxford Street will be workplace for 3,000 staff including CEO

A number of chemists have reported difficulties obtaining amoxicillin and penicillin as concern over infection grows

Pharma company Rigel’s (RIGL) REZLIDHIA recently achieved the U.S. Food and Drug Administration’s approval for treating relapsed or refractory acute myeloid leukemia, helping the stock to soar. RIGL shares have gained more than 30% over the past month. Given the industry tailwinds, RIGL might be the ideal stock to buy…

A bulk quantity of one kg contraband Brown Sugar and 1992 Kg ganja which were seized from the exclusive possession of accused persons, were destroyed by the STF on Monday at a designated incinerator. Read on for details:

Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, for about $26.4 billion

Beijing (AFP) - Covid cases are surging in the Chinese capital, officials said Monday, as the country navigates a rapid turn away from its zero-tolerance coronavirus strategy.